Sodium Reduction, miRNA Profiling and CVD Risk in Untreated Hypertensives: a Randomized, Double-Blind, Placebo-Controlled Trial

Sodium reduction decreases blood pressure (BP) and cardiovascular mortality. However, the underlying molecular mechanisms are not well understood. We tested the hypothesis that reduction of sodium intake would change miRNA expression in hypertensive patients, and those changes would be associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li, He, Feng J., Dong, Yanbin, Huang, Ying, Harshfield, Gregory A., Zhu, Haidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109065/
https://www.ncbi.nlm.nih.gov/pubmed/30143705
http://dx.doi.org/10.1038/s41598-018-31139-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109065/
https://www.ncbi.nlm.nih.gov/pubmed/30143705
http://dx.doi.org/10.1038/s41598-018-31139-5

Ejemplares similares